RELMADA THERAPEUTICS, INC. - Common Stock, par value $0.001 par value per share (RLMD)

Historical Holders from Q4 2019 to Q3 2025

Symbol
RLMD on Nasdaq
CUSIP
75955J402
Type / Class
Equity / Common Stock, par value $0.001 par value per share
Shares outstanding
73.8M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
7.74M
Holdings value
$15.5M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
43
Number of buys
14
Number of sells
-19
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of RELMADA THERAPEUTICS, INC. - Common Stock, par value $0.001 par value per share (RLMD)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Ikarian Capital, LLC 4.8% $7.12M 3.54M Ikarian Capital, LLC Sep 30, 2025
Squadron Capital Management LLC 9.9% +61.7% $2.57M $974K 3.3M +60.9% Squadron Capital Management LLC Jun 30, 2025

Institutional Holders of RELMADA THERAPEUTICS, INC. - Common Stock, par value $0.001 par value per share (RLMD)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 7.74M $15.5M +$5.27M $2.01 43
2025 Q2 5.3M $3.18M -$312K $0.60 48
2025 Q1 6.22M $1.68M -$765K $0.27 43
2024 Q4 8.4M $4.36M -$9.89M $0.52 48
2024 Q3 12.4M $40.2M -$3.63M $3.24 71
2024 Q2 13.6M $40.7M -$3.05M $3.00 79
2024 Q1 14.3M $66.5M +$4.42M $4.65 90
2023 Q4 13.6M $56.3M -$3.18M $4.14 82
2023 Q3 15M $45M -$3.17M $3.00 87
2023 Q2 16.1M $39.6M -$4.05M $2.46 90
2023 Q1 17.8M $40.1M -$4.35M $2.26 87
2022 Q4 19.1M $66.8M -$456M $3.49 105
2022 Q3 25.7M $953M +$76.7M $37.02 128
2022 Q2 24.2M $460M +$33.7M $18.99 102
2022 Q1 22.8M $616M +$64.1M $26.99 105
2021 Q4 20.7M $467M +$239M $22.53 89
2021 Q3 10M $263M -$4.61M $26.21 82
2021 Q2 9.94M $318M +$11.9M $32.01 82
2021 Q1 9.53M $335M +$11.9M $35.21 78
2020 Q4 9.04M $290M -$48.4M $32.07 77
2020 Q3 10.2M $383M -$2.36M $37.62 70
2020 Q2 10.5M $469M +$57.8M $44.75 73
2020 Q1 9.36M $319M +$94.7M $34.11 42
2019 Q4 6.8M $265M +$214M $39.00 43